Effect of polyphenols on HER2-positive breast cancer and related miRNAs: Epigenomic regulation

María Zabaleta; Tamara Y. Forbes‐Hernández; Jesus Simal Gandara; José L. Quiles; Danila Cianciosi; Beatriz Bullón; Francesca Giampieri; Maurizio Battino

doi:10.1016/j.foodres.2020.109623

Related publications

Article2014

Low protein expression of MET in ER-positive and HER2-positive breast cancer.

Flora Zagouri, Anita Brandstetter, Dimitrios Moussiolis, Dimosthenis Chrysikos, Constantine Dimitrakakis, Alexandra Tsigginou, Spyridon S Marinopoulos, George Zografos, Theodoros Ν. Sergentanis, Meletios A Dimopoulos, Martin Filipits

Article2021

Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review

Anastasios Kyriazoglou, Maria Kaparelou, G. Goumas, Michalis Liontos, Roubini Zakopoulou, Eleni Zografos, Anna Zygogianni, Meletios A Dimopoulos, Flora Zagouri

Article2016

Epigenetic silencing of TGFβ1, BCL6, KILLIN and CTSZ is related to trastuzumab resistance in HER2-positive breast cancer models

Sònia Palomeras Pairet, Ángel Diaz Lagares, Ariadna Sarrats Carbó, Ana-Belen Crujeiras, Ariadna Giró Perafita, Juan Sandoval, Mariona Rabionet, Manel Esteller, Teresa Puig

Article2016

Epigenetic silencing of TGFβ1, BCL6, KILLIN and CTSZ is related to trastuzumab resistance in HER2-positive breast cancer models

Sònia Palomeras Pairet, Ángel Diaz Lagares, Ariadna Sarrats Carbó, Ana-Belen Crujeiras, Ariadna Giró Perafita, Juan Sandoval, Mariona Rabionet, Manel Esteller, Teresa Puig

Article2016

Abstract 2130A: Epigenetic silencing of TGFβ1, BCL6, KILLIN and CTSZ is related to trastuzumab resistance in HER2-positive breast cancer models

Sònia Palomeras, Ángel Díaz‐Lagares, Ariadna Sarrats, Crujeiras Ana Belen, Ariadna Giró‐Perafita, Juan Sandoval, Marc Rabionet, Manel Esteller, Teresa Puig

Effect of polyphenols on HER2-positive breast cancer and related miRNAs: Epigenomic regulation

Discussion(0)

Related publications

Low protein expression of MET in ER-positive and HER2-positive breast cancer.

Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review

Epigenetic silencing of TGFβ1, BCL6, KILLIN and CTSZ is related to trastuzumab resistance in HER2-positive breast cancer models

Epigenetic silencing of TGFβ1, BCL6, KILLIN and CTSZ is related to trastuzumab resistance in HER2-positive breast cancer models

Abstract 2130A: Epigenetic silencing of TGFβ1, BCL6, KILLIN and CTSZ is related to trastuzumab resistance in HER2-positive breast cancer models